| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.044 | 0.8 |